Physician profile
David B Mccain
NPI 1912978800
$3,237.68
in general payments reported to CMS, 2019-2025
22 companies · $375 in 2025
The $375 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $563 · 2020: $240 · 2021: $679 · 2022: $321 · 2023: $338 · 2024: $722 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,434.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,477.22 | 2019-2024 | Coroflow, Jeti All In One Non-Sterile Kit, Cardiomems |
| Medtronic, INC. | $278.61 | 2023-2025 | Symplicity G3, Corevalve Evolut R, In.Pact Admiral |
| Abiomed | $200.78 | 2023 | Impella |
| Novartis Pharmaceuticals Corporation | $185.28 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $155.90 | 2019-2024 | Lifevest |
| Heartflow, INC. | $133.50 | 2022 | |
| Pfizer INC. | $130.94 | 2021-2025 | |
| Cleerly, INC. | $99.91 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Recor Medical INC | $94.96 | 2024 | Paradise Renal Denervation System |
| Astellas Pharma US INC | $77.61 | 2019 | |
| Medtronic Vascular, INC. | $73.48 | 2019 | |
| Boston Scientific Corporation | $48.28 | 2019 | |
| Amgen INC. | $47.92 | 2021-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $41.62 | 2024-2025 | Camzyos |
| Inari Medical, INC. | $38.79 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $31.47 | 2025 | Flowtriever |
| Inspire Medical Systems, INC. | $30.91 | 2025 | Inspire |
| Shockwave Medical, INC | $25.65 | 2021 | |
| Novo Nordisk INC | $24.84 | 2025 | Wegovy |
| Cook Medical LLC | $15.72 | 2021 | |
| Cardiovascular Systems INC. | $12.29 | 2019 | |
| Linus Health, INC. | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mccain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.